Johnson Johnson Stock Current Valuation

JNJ Stock

USD 155.17 0.33 0.21%

Valuation analysis of Johnson Johnson helps investors to measure Johnson Johnson's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is expected to hike to about 185.8 B this year, although Enterprise Value Over EBITDA will most likely fall to 10.10. Fundamental drivers impacting Johnson Johnson's valuation include:

Price Book

5.325

Enterprise Value

389 B

Enterprise Value Ebitda

15.1491

Price Sales

4.2601

Forward PE

14.5138

Overvalued

Today

155.17

Please note that Johnson Johnson's price fluctuation is very steady at this time. Calculation of the real value of Johnson Johnson is based on 3 months time horizon. Increasing Johnson Johnson's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.

Buy or Sell Advice Valuation Matrix

Johnson Johnson's intrinsic value may or may not be the same as its current market price of 155.17, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.

Historical

Market 155.17

Real 140.87

Target 168.46

Hype 155.09

Naive 158.88

The intrinsic value of Johnson Johnson's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Johnson Johnson's stock price.

140.09

Downside

140.87

Real Value

Target Odds

Above Odds

Below Odds

170.69

Upside

Estimating the potential upside or downside of Johnson Johnson helps investors to forecast how Johnson stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Johnson Johnson more accurately as focusing exclusively on Johnson Johnson's fundamentals will not take into account other important factors:

Earnings

Estimates (0)

Low	Projected	High
2.46	2.49	2.52

Details

Hype

Prediction

Low	Estimated	High
154.31	155.09	155.87

Details

Potential

Annual Dividend

Low	Forecasted	High
3.12	3.17	3.22

Details

24 Analysts

Consensus

Low	Target Price	High
153.30	168.46	186.99

Details

Johnson Johnson Company Current Valuation Analysis

Johnson Johnson's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Johnson Johnson Current Valuation

389.04 B

Most of Johnson Johnson's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Johnson Johnson is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Johnson Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Johnson Johnson is extremely important. It helps to project a fair market value of Johnson Stock properly, considering its historical fundamentals such as Current Valuation. Since Johnson Johnson's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Johnson Johnson's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Johnson Johnson's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.73	0.66	0.92	0.85	0.96	0.64	0.35	0.74	0.88	0.13	0.85	0.85	0.8	0.88	-0.71	0.89	-0.01	-0.64	0.76	0.72	0.35	0.55	-0.62	0.43	-0.37
Total Stockholder Equity	0.73		0.33	0.58	0.85	0.55	0.95	0.54	0.58	0.8	0.52	0.87	0.87	0.53	0.67	-0.2	0.8	-0.07	-0.08	0.36	0.34	0.37	0.31	-0.05	0.13	-0.11
Net Debt	0.66	0.33		0.48	0.55	0.78	0.21	0.28	0.73	0.69	0.06	0.27	0.27	0.82	0.77	-0.41	0.53	-0.06	-0.78	0.81	0.77	0.45	0.77	-0.69	0.54	-0.46
Retained Earnings	0.92	0.58	0.48		0.68	0.87	0.53	0.26	0.49	0.73	0.07	0.81	0.81	0.62	0.73	-0.89	0.84	0.05	-0.54	0.66	0.59	0.32	0.5	-0.52	0.44	-0.42
Net Receivables	0.85	0.85	0.55	0.68		0.8	0.76	0.29	0.86	0.93	0.15	0.86	0.86	0.84	0.92	-0.44	0.91	0.04	-0.53	0.72	0.71	0.32	0.35	-0.48	0.08	-0.14
Total Liab	0.96	0.55	0.78	0.87	0.8		0.45	0.21	0.8	0.85	-0.05	0.71	0.71	0.89	0.92	-0.76	0.84	0.01	-0.82	0.89	0.85	0.34	0.59	-0.79	0.43	-0.41
Total Current Assets	0.64	0.95	0.21	0.53	0.76	0.45		0.5	0.45	0.73	0.67	0.83	0.83	0.45	0.54	-0.15	0.69	-0.02	0.07	0.27	0.18	0.37	0.21	0.03	0.07	0.01
Short Term Debt	0.35	0.54	0.28	0.26	0.29	0.21	0.5		0.04	0.32	0.35	0.37	0.37	0.08	0.21	-0.03	0.34	-0.3	0.11	-0.02	-0.04	0.31	0.67	0.29	0.57	-0.54
Intangible Assets	0.74	0.58	0.73	0.49	0.86	0.8	0.45	0.04		0.8	-0.03	0.6	0.6	0.93	0.9	-0.33	0.71	0.06	-0.75	0.83	0.86	0.27	0.31	-0.7	0.0	-0.07
Accounts Payable	0.88	0.8	0.69	0.73	0.93	0.85	0.73	0.32	0.8		0.26	0.77	0.77	0.85	0.94	-0.53	0.92	-0.06	-0.57	0.77	0.72	0.49	0.48	-0.57	0.32	-0.28
Short Term Investments	0.13	0.52	0.06	0.07	0.15	-0.05	0.67	0.35	-0.03	0.26		0.24	0.24	-0.02	-0.01	0.26	0.08	0.04	0.47	-0.16	-0.32	0.49	0.06	0.3	0.09	0.2
Capital Stock	0.85	0.87	0.27	0.81	0.86	0.71	0.83	0.37	0.6	0.77	0.24		1.0	0.58	0.71	-0.53	0.87	-0.01	-0.29	0.48	0.45	0.23	0.23	-0.25	0.09	-0.15
Common Stock	0.85	0.87	0.27	0.81	0.86	0.71	0.83	0.37	0.6	0.77	0.24	1.0		0.58	0.71	-0.53	0.87	-0.01	-0.29	0.48	0.45	0.23	0.23	-0.25	0.09	-0.15
Long Term Debt	0.8	0.53	0.82	0.62	0.84	0.89	0.45	0.08	0.93	0.85	-0.02	0.58	0.58		0.93	-0.52	0.76	0.04	-0.82	0.96	0.9	0.3	0.51	-0.75	0.19	-0.22
Good Will	0.88	0.67	0.77	0.73	0.92	0.92	0.54	0.21	0.9	0.94	-0.01	0.71	0.71	0.93		-0.61	0.91	0.0	-0.78	0.89	0.88	0.41	0.52	-0.69	0.27	-0.36
Treasury Stock	-0.71	-0.2	-0.41	-0.89	-0.44	-0.76	-0.15	-0.03	-0.33	-0.53	0.26	-0.53	-0.53	-0.52	-0.61		-0.69	-0.03	0.65	-0.68	-0.61	-0.22	-0.45	0.6	-0.44	0.49
Property Plant Equipment	0.89	0.8	0.53	0.84	0.91	0.84	0.69	0.34	0.71	0.92	0.08	0.87	0.87	0.76	0.91	-0.69		-0.09	-0.55	0.72	0.7	0.38	0.45	-0.46	0.29	-0.38
Current Deferred Revenue	-0.01	-0.07	-0.06	0.05	0.04	0.01	-0.02	-0.3	0.06	-0.06	0.04	-0.01	-0.01	0.04	0.0	-0.03	-0.09		-0.03	0.03	-0.05	0.06	-0.09	-0.13	-0.45	0.15
Net Tangible Assets	-0.64	-0.08	-0.78	-0.54	-0.53	-0.82	0.07	0.11	-0.75	-0.57	0.47	-0.29	-0.29	-0.82	-0.78	0.65	-0.55	-0.03		-0.89	-0.92	-0.17	-0.48	0.9	-0.28	0.38
Long Term Debt Total	0.76	0.36	0.81	0.66	0.72	0.89	0.27	-0.02	0.83	0.77	-0.16	0.48	0.48	0.96	0.89	-0.68	0.72	0.03	-0.89		0.93	0.27	0.54	-0.82	0.27	-0.3
Deferred Long Term Liab	0.72	0.34	0.77	0.59	0.71	0.85	0.18	-0.04	0.86	0.72	-0.32	0.45	0.45	0.9	0.88	-0.61	0.7	-0.05	-0.92	0.93		0.15	0.46	-0.82	0.25	-0.22
Long Term Investments	0.35	0.37	0.45	0.32	0.32	0.34	0.37	0.31	0.27	0.49	0.49	0.23	0.23	0.3	0.41	-0.22	0.38	0.06	-0.17	0.27	0.15		0.35	-0.22	0.25	-0.32
Short Long Term Debt	0.55	0.31	0.77	0.5	0.35	0.59	0.21	0.67	0.31	0.48	0.06	0.23	0.23	0.51	0.52	-0.45	0.45	-0.09	-0.48	0.54	0.46	0.35		-0.28	0.75	-0.73
Cash And Equivalents	-0.62	-0.05	-0.69	-0.52	-0.48	-0.79	0.03	0.29	-0.7	-0.57	0.3	-0.25	-0.25	-0.75	-0.69	0.6	-0.46	-0.13	0.9	-0.82	-0.82	-0.22	-0.28		-0.25	0.13
Net Invested Capital	0.43	0.13	0.54	0.44	0.08	0.43	0.07	0.57	0.0	0.32	0.09	0.09	0.09	0.19	0.27	-0.44	0.29	-0.45	-0.28	0.27	0.25	0.25	0.75	-0.25		-0.6
Net Working Capital	-0.37	-0.11	-0.46	-0.42	-0.14	-0.41	0.01	-0.54	-0.07	-0.28	0.2	-0.15	-0.15	-0.22	-0.36	0.49	-0.38	0.15	0.38	-0.3	-0.22	-0.32	-0.73	0.13	-0.6

Click cells to compare fundamentals

Johnson Current Valuation Historical Pattern

Today, most investors in Johnson Johnson Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Johnson Johnson's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Johnson Johnson current valuation as a starting point in their analysis.

Johnson Johnson Current Valuation

Timeline

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Competition

Predict Johnson Johnson

Enterprise Value Over Time

In accordance with the recently published financial statements, Johnson Johnson has a Current Valuation of 389.04 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is significantly lower than that of the firm.

Johnson Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Johnson Johnson's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Johnson Johnson could also be used in its relative valuation, which is a method of valuing Johnson Johnson by comparing valuation metrics of similar companies.

Johnson Johnson is currently under evaluation in current valuation category among its peers.

Johnson Johnson ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Johnson Johnson's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Johnson Johnson's managers, analysts, and investors.

Environmental

Governance

Social

Johnson Fundamentals

	Return On Equity	0.21
	Return On Asset	0.084
	Profit Margin	0.17 %
	Operating Margin	0.25 %
	Current Valuation	389.04 B
	Shares Outstanding	2.41 B
	Shares Owned By Insiders	0.09 %
	Shares Owned By Institutions	73.11 %
	Number Of Shares Shorted	18.11 M
	Price To Earning	24.69 X
	Price To Book	5.33 X
	Price To Sales	4.26 X
	Revenue	85.16 B
	Gross Profit	63.95 B
	EBITDA	29.34 B
	Net Income	13.33 B
	Cash And Equivalents	5.37 B
	Cash Per Share	13.03 X
	Total Debt	29.33 B
	Debt To Equity	0.43 %
	Current Ratio	1.43 X
	Book Value Per Share	29.14 X
	Cash Flow From Operations	22.79 B
	Short Ratio	3.13 X
	Earnings Per Share	6.05 X
	Price To Earnings To Growth	0.92 X
	Target Price	174.89
	Number Of Employees	131.9 K
	Beta	0.52
	Market Capitalization	373.59 B
	Total Asset	167.56 B
	Retained Earnings	153.84 B
	Working Capital	7.21 B
	Current Asset	60.21 B
	Current Liabilities	27.75 B
	Annual Yield	0.03 %
	Five Year Return	2.59 %
	Net Asset	167.56 B
	Last Dividend Paid	4.86

About Johnson Johnson Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Johnson Johnson's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Johnson Johnson using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Johnson Johnson based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:

How To Invest In Johnson

Details

Is Johnson Stock a good investment?

Details

What is Johnson Johnson's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Johnson Johnson Piotroski F Score and Johnson Johnson Altman Z Score analysis.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.89)

Dividend Share

4.86

Earnings Share

6.05

Revenue Per Share

36.428

Quarterly Revenue Growth

0.052

The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Johnson Johnson Stock Current Valuation

Johnson Johnson Company Current Valuation Analysis

Enterprise Value

Market Cap + Debt

-

Cash

Current Johnson Johnson Current Valuation

Johnson Current Valuation Driver Correlations

Johnson Current Valuation Historical Pattern

Johnson Current Valuation Peer Comparison

Johnson Johnson ESG Sustainability

Johnson Fundamentals

About Johnson Johnson Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY